VX-548
VX-548 is a pharmaceutical drug with 11 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
11 of 11 finished
0.0%
0 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment
Clinical Trials (11)
Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment
Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants
A Study to Evaluate the Pharmacokinetic Drug-drug Interactions Between VX-548, Midazolam, and Digoxin
A Study to Evaluate the Effect of Food on the Pharmacokinetics of VX-548
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548
Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Mild or Moderate Hepatic Impairment
A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11